Abstract
A facile and low-cost approach is developed to fabricate a novel CuS/SiO2-based nanotherapeutic agent for dual-model imaging guided photodynamic/photothermal combined cancer therapy. In this design, mesoporous silica nanoparticles (MSN) with nanosized CuS bundled in the channel are obtained in aqueous solution via the in situ growth route for the first time. Furthermore, to achieve a more efficient therapy, photosensitizer complex Ir-2 and bovine serum albumin (BSA) are sequentially assembled via layer-by-layer method. The as-prepared complex Ir-2 presents a remarkably high singlet oxygen (1O2) generation (ΦΔ = 1.3) under light illumination to offer effective photodynamic cell killing, and MSN/CuS exhibits high photothermal conversion efficiency (η = 31.7%) under illumination by 808 nm light to offer hyperthermia tumor ablation. In vitro and in vivo analyses show that the nanotherapeutic agent exhibits excellent performance in tumor therapy even under irradiation with low-power due to the high yield of 1O2 combined with the high photothermal conversion efficiency. Additionally, the nanotherapeutic agent is readily visualized in vivo via near-infrared fluorescence and thermal imaging. More importantly, based on the strategy of in situ growth and layer-by-layer assembly developed in this work, the development of other highly efficient “all-in-one” multifunctional theranostic platform can be predictable.
Funding Information
  • China Postdoctoral Science Foundation (2016M601789)
  • Government of Jiangsu Province (17KJB430025)
  • National Natural Science Foundation of China (21401108, 51473078, 61775103, 21671108)
  • Central Committee of the Communist Party of China
  • Scientific and Technological Innovation Teams of Colleges and Universities in Jiangsu Province (TJ215006)

This publication has 49 references indexed in Scilit: